Abstract
Background: Post-discharge venous thromboembolism (VTE) chemoprophylaxis decreases VTEs following cancer surgery, however identifying high-risk patients remains difficult. Our objectives were to (1) identify factors available at hospital discharge associated with post-discharge VTE following hepatectomy for malignancy and (2) develop and validate a post-discharge VTE risk calculator to evaluate patient-specific risk. Methods: Patients who underwent hepatectomy for malignancy from 2014 to 2017 were identified from the ACS NSQIP hepatectomy procedure targeted module. Multivariable logistic regression identified factors associated with post-discharge VTE. A post-discharge VTE risk calculator was constructed, and predicted probabilities of post-discharge VTE were calculated. Results: Among 11 172 patients, 95 (0.9%) developed post-discharge VTE. Post-discharge VTE was associated with obese BMI (OR 2.29 vs. normal BMI [95%CI 1.31–3.99]), right hepatectomy/trisegmentectomy (OR 1.63 vs. partial/wedge [95%CI 1.04–2.57]), and several inpatient postoperative complications: renal insufficiency (OR 5.29 [95%CI 1.99–14.07]), transfusion (OR 1.77 [95%CI 1.12–2.80]), non-operative procedural intervention (OR 2.97 [95%CI 1.81–4.86]), and post-hepatectomy liver failure (OR 2.22 [95%CI 1.21–4.08]). Post-discharge VTE risk ranged from 0.3% to 30.2%. Twenty iterations of 10-fold cross validation identified internal validity. Conclusions: Risk factors from all phases of care, including inpatient complications, are associated with post-discharge VTE following hepatectomy. Identifying high-risk patients may allow for personalized risk-based post-discharge chemoprophylaxis prescribing.
Original language | English (US) |
---|---|
Pages (from-to) | 723-732 |
Number of pages | 10 |
Journal | HPB |
Volume | 23 |
Issue number | 5 |
DOIs | |
State | Published - May 2021 |
Funding
This study was supported by the Northwestern Institute for Comparative Effectiveness Research in Oncology (NICER-Onc) of the Robert H. Lurie Comprehensive Cancer Center. RJE was supported by a postdoctoral research fellowship from the Agency for Healthcare Research and Quality ( 5T32HS000078 ). RPM is supported by the Agency for Healthcare Research and Quality ( K12HS026385 ) and an Institutional Research Grant from the American Cancer Society ( IRG-18-163-24 ), ADY is supported by the National Heart, Lung and Blood Institute ( K08NIHL145139 ), DJB is supported by the Veteran's Administration ( I01HX002290 ). These funding sources were not involved in the study design, collection, analysis or interpretation of data, writing of the report, nor the decision to submit the article for publication.
ASJC Scopus subject areas
- Hepatology
- Gastroenterology